These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 5290167)

  • 1. [Immunoelectrophoretic studies of serum proteins in patients with Hodgkin's disease and acute myeloid leukemia].
    Singer Z; Salwa J; Harlozińska A
    Pol Tyg Lek; 1971 Nov; 26(48):1859-62. PubMed ID: 5290167
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunoelectrophoretic studies of blood serum proteins in patients with malignant lymphogranulomatosis].
    Adamczyk B; Glińska H; Kulpa J
    Przegl Lek; 1971; 28(12):759-62. PubMed ID: 5139317
    [No Abstract]   [Full Text] [Related]  

  • 3. [The morpho-functional test of blood lymphocytes in proliferative blood diseases. Case reports].
    D'Arrigo S; Lanza C; Lazzaro C
    Riv Patol Clin Sper; 1968; 9(1):3-18. PubMed ID: 4973516
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparison of paper electrophoretic and immunoelectrophoretic studies of the serum proteins of patients with lymphomas and leukemias.
    Leoncini D; Forni A; Korngold L; Miller DG
    Oncology; 1968; 22(2):81-117. PubMed ID: 4880062
    [No Abstract]   [Full Text] [Related]  

  • 5. [Contribution of immunoelectrophoresis to the study of malignant hemopathies (leukoses and Hodgkin's disease].
    GOUDEMAND M; FOUCAUT M
    Lille Med; 1960 Jun; 5():394-400. PubMed ID: 13707476
    [No Abstract]   [Full Text] [Related]  

  • 6. Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis.
    Mitarnun W; Pradutkanchana J; Takao S; Saechan V; Suwiwat S; Ishida T
    J Med Assoc Thai; 2002 May; 85(5):552-9. PubMed ID: 12188384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.
    Bianco E; Marcucci F; Mele A; Musto P; Cotichini R; Sanpaolo MG; Iannitto E; De Renzo A; Martino B; Specchia G; Montanaro M; Barbui AM; Nieddu R; Pagano L; Rapicetta M; Franceschi S; Mandelli F; Pulsoni A;
    Haematologica; 2004 Jan; 89(1):70-6. PubMed ID: 14754608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Utilization of "anti-serum specific" immune serums for the study of abnormal circulating proteins (in acute leukemia, Hodgkin's disease and disseminated lupus erythematosus)].
    CAETANO JA; da COSTA S; SOARES AD; da SILVA J
    Gaz Med Port; 1960; 13():575-82. PubMed ID: 13689743
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum copper levels in lymphoma and leukemia. Special reference to Hodgkin's disease.
    Hrgovcic M; Tessmer CF; Minckler TM; Mosier B; Taylor GH
    Cancer; 1968 Apr; 21(4):743-55. PubMed ID: 4868473
    [No Abstract]   [Full Text] [Related]  

  • 10. [Characteristics of cholesterol and protein metabolism in patients with chronic leukoses and lymphogranulomatosis].
    Sarnitskiĭ IP; Ishchenko VT
    Vrach Delo; 1973 Jun; 6():62-4. PubMed ID: 4755134
    [No Abstract]   [Full Text] [Related]  

  • 11. [Serum complement level in Hodgkin's disease].
    Hamladji RM; Belhani M; Irunberry J; Benabadji M; Colonna P
    Nouv Rev Fr Hematol; 1972; 12(5):673-81. PubMed ID: 4120941
    [No Abstract]   [Full Text] [Related]  

  • 12. [Acute myeloid leukemia coexisting with Hodgkin's disease].
    Udolf E; Kośmiderski Z; Król J; Labryga J; Czepiel L
    Pol Tyg Lek; 1973 Aug; 28(32):1238-9. PubMed ID: 4518462
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum hydroxyproline and Hodgkin's disease.
    Hvidberg E; Rasmussen S
    Mater Med Pol; 1973; 5(3):206-8. PubMed ID: 4749979
    [No Abstract]   [Full Text] [Related]  

  • 14. Hodgkin's disease terminating in acute erythromyeloblastic leukemia with diabetes insipidus. A case report and review.
    Bergevin PR; Blom J
    Med Ann Dist Columbia; 1972 Oct; 41(10):625-9. PubMed ID: 4507110
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes in the proteinogram and serum immunoglobulins in acute and chronic myeloleukosis].
    Sarnitskiĭ IP; Tishchenko LM; Guseva SA; Minchenko ZhN
    Vrach Delo; 1984 Jan; (1):90-3. PubMed ID: 6583885
    [No Abstract]   [Full Text] [Related]  

  • 16. [Acute myeloic leukemia as a late complication of Hodgkin's disease].
    Ho AD; Hunstein W; Uhl N
    MMW Munch Med Wochenschr; 1979 Apr; 121(15):521-2. PubMed ID: 108565
    [No Abstract]   [Full Text] [Related]  

  • 17. Second malignant neoplasms in patients successfully treated for Hodgkin's disease: a Cancer and Leukemia Group B study.
    Glicksman AS; Pajak TF; Gottlieb A; Nissen N; Stutzman L; Cooper MR
    Cancer Treat Rep; 1982 Apr; 66(4):1035-44. PubMed ID: 6951632
    [No Abstract]   [Full Text] [Related]  

  • 18. Elevated plasma levels of a hydroxyproline-containing protein in Hodgkin's disease and their relation to disease activity.
    Leroy EC; Carbone PP; Sjoerdsma A
    J Lab Clin Med; 1966 Jun; 67(6):891-7. PubMed ID: 5330920
    [No Abstract]   [Full Text] [Related]  

  • 19. Coexistent Hodgkin's disease and acute myeloid leukaemia.
    Pal AK; Chopra SK; Grover J; Verma RN
    J Assoc Physicians India; 1974 Feb; 22(2):199-201. PubMed ID: 4526532
    [No Abstract]   [Full Text] [Related]  

  • 20. [Serum proteins in neoplasms and in malignant productive hemolymphopathies evalued by the technic of immunoelectrophoresis].
    Fedeli S; Ranieri MG
    Cancro; 1969; 22(2):273-86. PubMed ID: 4911534
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.